Stock listing
OTC:PBIO Pressure BioSciences, Inc. Stock
Follow Pressure BioSciences, Inc. into a list and get an email when it puts out news.
Share price · OTC:PBIO
$0.0002 USD 0.0000 (0.0%)
Close on Nov 20, 2026
Past year -66.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits- Day range
- $0.0002 – $0.0002 USDNov 20, 2026
- Volume
- 8,006 sharesNov 20, 2026
- Market cap
- $8,193 USDAt the close on Nov 20, 2026 · price × 40.97M shares outstanding
- 52-week range
- $0.0001 – $0.2000 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $1 USDMedian day 0 shares · 42 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:PBIO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 8,006 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 1,947 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 6,091 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0002 | 10,845 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 2,627 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 81,092 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | -0.0003 | -60.0% | $0.0002 | $0.0002 | $0.0002 | 25,927 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 334 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0002 | $0.0005 | $0.0002 | 700 |
|---|
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 1,000 |
|---|
| $0.0005 | +0.0003 | +150.0% | $0.0005 | $0.0005 | $0.0005 | 107,000 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 25,800 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0001 | $0.0002 | $0.0001 | 7,600 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
|---|
| $0.0002 | +0.0001 | +100.0% | $0.0002 | $0.0002 | $0.0002 | 500 |
|---|
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 800 |
|---|
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 |
|---|
| $0.0001 | -0.0003 | -75.0% | $0.0001 | $0.0001 | $0.0001 | 20,000 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0398 | $0.0398 | $0.0004 | 800 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 335 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 |
|---|
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 187 |
|---|
Splits
1 split · OTC:PBIO · every price before a split is adjusted for it
| Day | Ratio | What |
|---|
| 1-for-30 | Consolidation |
|---|
- Ticker
- OTC:PBIO
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Pressure BioSciences, Inc. on 6ix
- Calls
- 11 calls with a replay · 11 with a transcript · latest Nov 21, 2023
- Decks
- 19 decks · latest May 2023
Valuation
price Nov 20, 2026
- Enterprise value
- No statements on 6ix yet
- P/E
- No statements on 6ix yet
- EV/sales
- No statements on 6ix yet
- EV/EBITDA
- No statements on 6ix yet
- Price/book
- No statements on 6ix yet
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 0.52
Team and board
Officers
| Officer | Role |
|---|
| Richard T. Schumacher | President, Chief Executive Officer and Director |
|---|
| Edmund Ting | Senior Vice President of Engineering |
|---|
| Alexander Lazarev | Chief Science Officer |
|---|
Board
| Director | Role |
|---|
| Jeffrey N. Peterson | Chairman of the Board |
|---|
| Michael S. Urdea | Director |
|---|
| Richard T. Schumacher | President, Chief Executive Officer and Director |
|---|
Events
Calls
| Call | When | Status |
|---|
| Pressure BioSciences (OTC:PBIO) Q3 2023 Earnings Call | Tue, Nov 21, 2023 · 4:30 PM ET | Replay |
|---|
| Pressure BioSciences (OTC:PBIO) Q4 2022 Earnings Call | Tue, Apr 18, 2023 · 4:30 PM ET | Replay |
|---|
| Pressure BioSciences (OTC:PBIO) Q3 2022 Earnings Call | Tue, Nov 22, 2022 · 4:30 PM ET | Replay |
|---|
| Pressure BioSciences (OTC:PBIO) Q2 2022 Earnings Call | Thu, Aug 18, 2022 · 4:30 PM ET | Replay |
|---|
| Pressure BioSciences (OTC:PBIO) Q1 2022 Earnings Call | Thu, May 19, 2022 · 4:30 PM ET | Replay |
|---|
| Pressure BioSciences (OTC:PBIO) Q1 2023 Earnings Call | Mon, May 16, 2022 · 4:30 PM ET | Replay |
|---|
| Pressure BioSciences (OTC:PBIO) Q4 2021 Earnings Call | Tue, Apr 05, 2022 · 4:30 PM ET | Replay |
|---|
| Pressure BioSciences (OTC:PBIO) Q2 2021 Earnings Call | Thu, Aug 19, 2021 · 4:30 PM ET | Replay |
|---|
| Pressure BioSciences (OTC:PBIO) Q1 2021 Earnings Call | Wed, May 19, 2021 · 4:30 PM ET | Replay |
|---|
| Pressure BioSciences (OTC:PBIO) Q4 2020 Earnings Call | Wed, Apr 21, 2021 · 4:30 PM ET | Replay |
|---|
All 11 calls
Results days
| Quarter | Results | Share move |
|---|
| Quarter to Mar 31, 2026 | May 21, 2026 | 0.0% |
|---|
| Quarter to Dec 31, 2025 | Feb 25, 2026 | 0.0% |
|---|
| Quarter to Sep 30, 2025 | Nov 28, 2025 | −50.0% |
|---|
| Quarter to Jun 30, 2025 | Aug 29, 2025 | 0.0% |
|---|
| Quarter to Mar 31, 2025 | May 30, 2025 | 0.0% |
|---|
| Quarter to Dec 31, 2024 | Feb 7, 2025 | +100.0% |
|---|
| Quarter to Sep 30, 2024 | Dec 16, 2024 | +108.3% |
|---|
| Q2 2024 | Aug 15, 2024 | 0.0% |
|---|
| Q1 2024 | Jun 7, 2024 · After close | −7.7% |
|---|
| Q3 2023 | Nov 20, 2023 · After close | −8.0% |
|---|
All 19 quarters
| Quarter | Results | Share move |
|---|
| Q2 2023 | Aug 22, 2023 · After close | +0.3% |
|---|
| Q1 2023 | May 16, 2023 · After close | −1.0% |
|---|
| Q3 2022 | Nov 22, 2022 · After close | 0.0% |
|---|
| Q2 2022 | Aug 18, 2022 | +3.0% |
|---|
| Q1 2022 | Apr 5, 2022 | −6.8% |
|---|
| Q3 2021 | Nov 17, 2021 | −2.4% |
|---|
| Q2 2021 | Aug 19, 2021 | −5.8% |
|---|
| Q1 2021 | Apr 21, 2021 | +4.0% |
|---|
| Q4 2020 | Mar 31, 2021 | +2.4% |
|---|
Open Events
Financials
Annual, in USD
Income statement
| Line | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|
| Revenue | 1.98M | 1.73M | 2.00M | 1.22M | 1.81M | 2.46M | 2.24M | 1.98M | 1.80M | 1.37M |
|---|
| Cost of revenue | 1.18M | 2.01M | 942.4K | 582.9K | 1.20M | 1.28M | 1.27M | 834.0K | 1.71M | 586.0K |
|---|
| Gross profit | 799.6K | -284.7K | 1.06M | 637.7K | 612.9K | 1.18M | 967.1K | 1.14M | 83.3K | 1.37M |
|---|
| Research and development | 1.37M | 969.5K | 1.10M | 1.14M | 1.16M | 1.21M | 988.6K | 1.18M | 1.10M | 952.6K |
|---|
| Selling, general and administrative | 8.94M | 3.64M | 4.14M | 4.08M | 5.26M | 4.45M | 4.63M | 3.70M | 3.65M | 3.11M |
|---|
| Operating income | -9.50M | -4.90M | -4.19M | -4.59M | -5.81M | -4.48M | -4.65M | -3.74M | -3.57M | -3.34M |
|---|
| Depreciation and amortization | 112.5K | 119.8K | 110.1K | 5.56M | 1.48M | 1.61M | 8.58K | 17.9K | 25.3K | 1.38M |
|---|
| EBITDA | -9.39M | -4.78M | -4.08M | 978.4K | -4.33M | -2.87M | -4.64M | -3.72M | -3.54M | -1.96M |
|---|
| Interest expense | 15.6M | 10.4M | 14.5M | 8.34M | 5.28M | 4.17M | 0 | 0 | 0 | 0 |
|---|
| Income before tax | -29.3M | -16.1M | -20.2M | -16.0M | -11.9M | -9.70M | -10.7M | -2.71M | -7.42M | -4.61M |
|---|
| Income tax | | | | | -217.2K | 0 | 0 | 0 | 0 | 0 |
|---|
| Net income | -29.3M | -16.1M | -20.2M | -16.0M | -11.7M | -9.70M | -10.7M | -2.71M | -7.42M | -4.61M |
|---|
| Earnings per share, basic | -0.83 | -1.17 | -2.21 | -3.84 | -4.57 | -5.76 | -7.98 | -0.09 | | -0.25 |
|---|
Balance sheet
| Line | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|
| Cash and equivalents | 81.3K | 3.87K | 132.3K | 18.5K | 29.6K | 103.1K | 81.0K | 138.4K | 116.8K | 473.9K |
|---|
| Receivables | 151.2K | 295.4K | 154.7K | 131.2K | 229.4K | 474.8K | 206.8K | 281.3K | 113.3K | 272.0K |
|---|
| Inventory | 304.9K | 686.4K | 1.15M | 592.8K | 617.7K | 765.5K | 857.7K | 905.3K | 1.04M | 850.6K |
|---|
| Current assets | 760.1K | 1.24M | 1.86M | 1.06M | 1.09M | 1.51M | 1.37M | 1.59M | 1.49M | 1.71M |
|---|
| Property, plant and equipment | | | 511.4K | 16.5K | 132.2K | 205.7K | 22.7K | 9.41K | 20.1K | 36.0K |
|---|
| Total assets | 1.05M | 2.01M | 2.83M | 2.30M | 1.82M | 2.40M | 2.16M | 1.63M | 1.80M | 1.74M |
|---|
| Accounts payable | 1.32M | 637.2K | 527.9K | 3.23M | 815.8K | 658.9K | 589.3K | 407.2K | 941.4K | 1.91M |
|---|
| Current liabilities | 33.6M | 34.4M | 24.6M | 18.5M | 13.9M | 8.35M | 16.7M | 9.27M | 9.57M | 3.77M |
|---|
| Long-term debt | 161.9K | 150.0K | 150.0K | 527.0K | | 136.4K | | 655.3K | 177.3K | |
|---|
| Total liabilities | 33.8M | 34.7M | 25.0M | 19.2M | 13.9M | 8.52M | 16.8M | 10.0M | 9.78M | 3.80M |
|---|
| Shareholders' equity | -32.8M | -32.7M | -22.2M | -16.9M | -12.1M | -6.13M | -14.6M | -8.38M | -7.98M | -2.06M |
|---|
| Shares outstanding | 35.4M | 13.7M | 9.12M | 4.17M | 2.55M | 1.68M | 1.34M | 31.0M | | 18.7M |
|---|
Cash flow
| Line | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|
| Cash from operations | -3.19M | -4.48M | -4.87M | -4.88M | -6.33M | -5.70M | -3.90M | -3.81M | -3.82M | -3.21M |
|---|
| Capital spending | -7.50K | -20.8K | -122.9K | -1.66K | -23.4K | -23.4K | -21.8K | -7.20K | -9.41K | -7.14K |
|---|
| Free cash flow | -3.19M | -4.50M | -4.99M | -4.88M | -6.35M | -5.70M | -4.08M | -3.81M | -3.83M | -3.22M |
|---|
| Cash from investing | | | -122.9K | -796.7K | -23.4K | -23.4K | -171.8K | -7.20K | -9.41K | -7.14K |
|---|
| Cash from financing | 3.27M | 4.37M | 5.11M | 5.67M | 6.28M | 5.72M | 4.02M | 3.83M | 3.47M | 3.66M |
|---|
| Share buybacks | | | | 150.0K | 3.28M | 2.82M | 140.2K | 294.7K | 294.7K | 2.09M |
|---|
| Change in cash | 77.4K | -128.4K | 113.8K | -11.1K | -73.5K | 22.1K | -57.3K | 21.6K | -357.2K | 442.5K |
|---|
Open Financials
Cap table
Built by 6ix from Pressure BioSciences, Inc.’s releases
- Common shares
- 40,967,084
- Fully diluted
- 40,967,084
Fully diluted
| Line | Shares |
|---|
| Common shares | 40,967,084 |
|---|
Share count over time
| Count | Shares |
|---|
| Nov 22, 2026 | 40,967,084 |
|---|
Open Cap table
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|
| Kevin Pollack | Director · Jul 3, 2012 – Mar 27, 2024 · Past |
|---|
| Conrad F Mir | CFO · Nov 28, 2012 – Nov 28, 2012 · Past |
|---|
| J Donald Payne | Director · Mar 1, 2006 – Nov 7, 2011 · Past |
|---|
| Joseph Luis Damasio Jr | VP of FINANCE and CFO · Dec 20, 2011 – Dec 19, 2018 · Past |
|---|
| Alexander Lazarev | Chief Science Officer · Since at least Nov 5, 2026 |
|---|
| Edmund Ting | Senior Vice President of Engineering · Since at least Mar 30, 2010 |
|---|
| Jeffrey N. Peterson | Chairman of the Board · Since at least Nov 5, 2026 |
|---|
| Michael S. Urdea | Director · Since at least Apr 29, 2022 |
|---|
| Richard Thomley | Chief Financial Officer · Sep 27, 2013 – Dec 22, 2014 · Past |
|---|
| Richard T. Schumacher | President, Chief Executive Officer and Director · Since at least Mar 30, 2006 |
|---|
All 11 people
| Person | Seat |
|---|
| R Wayne Fritzsche | Director · Apr 15, 2008 – Aug 15, 2012 · Past |
|---|
Open People
Log in to ask 6ix AI your own questions about Pressure BioSciences, Inc.